Surfactant phospholipids: synthesis and storage
- PMID: 1566854
- DOI: 10.1152/ajplung.1992.262.4.L367
Surfactant phospholipids: synthesis and storage
Abstract
Pulmonary surfactant, a complex consisting of 90% lipids and 10% specific proteins, lines the alveoli of the lung and prevents alveolar collapse and transudation by lowering the surface tension at the air-liquid interface. Dipalmitoylphosphatidylcholine constitutes approximately 50% of the surfactant lipids and is primarily responsible for the surface tension-lowering property of the surfactant mixture. This phospholipid, together with the other surfactant phospholipids, is produced at the endoplasmic reticulum of the alveolar type II epithelial cells. The characteristic lamellar bodies in these cells serve as storage depot for the surfactant before this is secreted onto the alveolar surface. This article reviews the pathways via which the surfactant lipids are synthesized, our current knowledge of the regulation of these pathways, and what is known about intracellular traffic of phospholipids from their site of synthesis to the lamellar bodies.
Similar articles
-
Coordinate packaging of newly synthesized phosphatidylcholine and phosphatidylglycerol in lamellar bodies in alveolar type II cells.Lipids. 2000 Jan;35(1):35-43. doi: 10.1007/s11745-000-0492-3. Lipids. 2000. PMID: 10695922
-
Aspects of metabolism and storage of pulmonary surfactant: experiments with isolated type II pneumocytes and lamellar bodies.Eur J Respir Dis Suppl. 1987;153:182-8. Eur J Respir Dis Suppl. 1987. PMID: 3322861 Review.
-
Phospholipid metabolism in lung surfactant.Subcell Biochem. 2004;37:359-88. doi: 10.1007/978-1-4757-5806-1_11. Subcell Biochem. 2004. PMID: 15376627 Review.
-
Surfactant protein A accumulating in the alveoli of patients with pulmonary alveolar proteinosis: oligomeric structure and interaction with lipids.Am J Respir Cell Mol Biol. 1996 Jun;14(6):608-19. doi: 10.1165/ajrcmb.14.6.8652189. Am J Respir Cell Mol Biol. 1996. PMID: 8652189
-
Lysophosphatidylcholine Acyltransferase 1 (LPCAT1) Specifically Interacts with Phospholipid Transfer Protein StarD10 to Facilitate Surfactant Phospholipid Trafficking in Alveolar Type II Cells.J Biol Chem. 2015 Jul 24;290(30):18559-74. doi: 10.1074/jbc.M115.666701. Epub 2015 Jun 5. J Biol Chem. 2015. PMID: 26048993 Free PMC article.
Cited by
-
Coordinate packaging of newly synthesized phosphatidylcholine and phosphatidylglycerol in lamellar bodies in alveolar type II cells.Lipids. 2000 Jan;35(1):35-43. doi: 10.1007/s11745-000-0492-3. Lipids. 2000. PMID: 10695922
-
Multiomics links global surfactant dysregulation with airflow obstruction and emphysema in COPD.ERJ Open Res. 2022 May 15;9(3):00378-2022. doi: 10.1183/23120541.00378-2022. eCollection 2023 May. ERJ Open Res. 2022. PMID: 37228288 Free PMC article.
-
Phospholipid Remodeling in Physiology and Disease.Annu Rev Physiol. 2019 Feb 10;81:165-188. doi: 10.1146/annurev-physiol-020518-114444. Epub 2018 Oct 31. Annu Rev Physiol. 2019. PMID: 30379616 Free PMC article. Review.
-
Solubility versus electrostatics: what determines lipid/protein interaction in lung surfactant.Biophys J. 2007 Aug 15;93(4):1192-203. doi: 10.1529/biophysj.107.106765. Epub 2007 May 18. Biophys J. 2007. PMID: 17513378 Free PMC article.
-
Sucrose- and fat-related metabolic states influence the adaptation of the pulmonary lipid metabolism to hypoxia.Cell Tissue Res. 2025 Jul;401(1):69-81. doi: 10.1007/s00441-025-03968-0. Epub 2025 Apr 1. Cell Tissue Res. 2025. PMID: 40167611 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources